FRE — Fresenius SE & Co. KGaA Share News
0.000.00%
Last trade - 00:00- €26.47bn
- €35.49bn
- €22.87bn
Brief: Fresenius Announces FDA And EMA Acceptance For Review Of Vedolizumab Biosimilar Candidate
Brief: Fresenius Says FDA And EMA Accepted Vedolizumab Biosimilar Candidate For Review
Top of the Street: Veolia, Fresenius Medical Care, Temenos and Talanx
Exane cuts Fresenius Medical Care, cites US volume concerns
Brief: Fresenius Establishes Venture Fund Of More Than €200 Million
Brief: Fresenius Commits Over EUR 200 Mln To Healthcare Innovation Through Ventures Fund
Europe Research Roundup: Belimo Holding, HSBC, Standard Chartered
European chemical earnings to test demand recovery after conflict-led pricing boost
ING Bank N.V. London - Post-Stabilisation Notice - Fresenius
Brief: Fresenius Says Successfully Issued EUR 1 Billion In Bonds
Morgan Stanley sees selective medtech opportunities on growth recovery
Brief: Fresenius Shareholders Approve All Agenda Items At 2026 AGM
Europe Research Roundup: ACS, Endeavour Mining, IHG
Germany's Fresenius reports revenue and profit miss for Q1 (updated)
Brief: Fresenius Q1 EBIT Before Special Items At EUR 678 Mln
Brief: Fresenius Invests In Avelios Medical With SAP
Germany's Fresenius posts revenue miss for Q1
Fresenius Medical Care's revenue falls in Q1 as weak dollar takes toll (updated)
Europe Research Roundup: ADP, Bawag Group, Technip Energies